Explore evidence

66.8 %In a trial in Burkina Faso and Mali, the protective efficacy of RTS,S/AS01E combined with seasonal malaria chemoprevention (SMC) was 66.8% against death from malaria.

Burkina Faso · MalipaludismeHAL · Unilimdocument of 105 observations

3,771,426 casesIn 2023, the National Malaria Control Program in Mali recorded 3,771,426 clinical malaria cases.

Malipaludismeobserved 2023HAL · Unilimdocument of 95 observations

251 cases_per_1000_person_yearsHealth districts with incidence rates between 251 and 450 cases per 1,000 person-years or Pf/Pv prevalence between 10% and 35% were classified as 'Moderate Transmission Zones'.

Malipaludisme · Pf/PvHAL · Unilimdocument of 95 observations

90 %P. falciparum représentait plus de 90 % des espèces plasmodiales détectées.

MalipaludismeHAL · Unilimdocument of 214 observations

Malaria incidence increased slightly in Mali between 2017 and 2022.

Malipaludismeobserved 2017–2022HAL · Unilimdocument of 111 observations

7.6 %In children who received RTS,S/AS01E vaccine in Burkina Faso and Mali, 7.6% showed a 10-fold increase in anti-CSP IgG antibody titres post-2020 as measured by GSK ELISA.

Burkina Faso · Malipaludismeobserved post-2020HAL · Unilimdocument of 105 observations

3.43 odds_ratioDuring the dry season, the risk of anemia was higher among malaria-infected pregnant women, with an odds ratio of 3.43.

Malianémie · paludismeobserved 1994published 2003Acta tropicaeurope_pmcdocument of 8 observations

19.5 %La prévalence du paludisme chez les enfants de moins de 5 ans était de 19,5 %.

MalipaludismeHAL · Unilimdocument of 214 observations

28.5 %Les stades schizontes ont été retrouvés chez 28,5 % des porteurs de P. malariae.

MalipaludismeHAL · Unilimdocument of 214 observations

5,990 participantsA total of 5,990 participants were recruited and followed from day 0 to day 28 in clinical trials of malaria treatments in Mali.

Malipaludismepublished 2014Malaria journaleurope_pmcdocument of 4 observationsDOI 10.1186/1475-2875-13-358

0 casAucun cas de Plasmodium vivax n’a été détecté.

MalipaludismeHAL · Unilimdocument of 214 observations

64.6 %In children who received RTS,S/AS01E vaccine in Burkina Faso and Mali, 64.6% showed a 2-fold increase in anti-CSP IgG antibody titres post-2020 as measured by Oxford MSD assay.

Burkina Faso · Malipaludismeobserved post-2020HAL · Unilimdocument of 105 observations

7.4 %Elevated direct bilirubin was noted in 7.40% of treated malaria episodes.

Malipaludismepublished 2021Malaria journaleurope_pmcdocument of 14 observationsDOI 10.1186/s12936-021-03593-6

99 %The adequate clinical and parasite response rate corrected by polymerase chain reaction (ACPRc) for the first-line artemether-lumefantrine (AL) treatment at Mali study sites was 99.0%.

Malipaludismepublished 2021Malaria journaleurope_pmcdocument of 2 observationsDOI 10.1186/s12936-021-03890-0

0.43 hazard_ratioChildren whose antibody response was in the upper tercile post-vaccination had a lower incidence of malaria during the following year than children in the lowest tercile, with a hazard ratio of 0.43.

Malipaludismeobserved following yearpublished 2022Clinical infectious diseases : an official publication of the Infectious Diseases Society europe_pmcdocument of 3 observations

A sharp seasonality in malaria illness incidence was observed with higher clinical malaria incidence rates during the rainy season in Bandiagara, Mali.

Malipaludismepublished 2014Malaria journaleurope_pmcdocument of 3 observationsDOI 10.1186/1475-2875-13-374

0.46 adjusted_risk_ratioIn the individual participant data meta-analysis, treatment significantly decreased Plasmodium falciparum prevalence with an adjusted risk ratio of 0.46.

Malipaludismepublished 2020The Lancet. Global healtheurope_pmcdocument of 6 observationsDOI 10.1016/s2214-109x(20)30325-9

15 %Dans les zones forestières et de savane humide d'Afrique de l'Ouest et du centre, la prévalence de P. malariae à l'examen d'une goutte épaisse atteint souvent 15 à 40 %.

MalipaludismeHAL · Unilimdocument of 214 observations

57.7 %In a trial in Burkina Faso and Mali, the protective efficacy of RTS,S/AS01E combined with seasonal malaria chemoprevention (SMC) was 57.7% against clinical episodes of malaria.

Burkina Faso · MalipaludismeHAL · Unilimdocument of 105 observations

88.6 %In children who received RTS,S/AS01E vaccine in Burkina Faso and Mali, 88.6% showed a 10-fold increase in anti-CSP IgG antibody titres post-2017 as measured by Oxford MSD assay.

Burkina Faso · Malipaludismeobserved post-2017HAL · Unilimdocument of 105 observations

La fréquence de P. malariae était plus élevée chez les porteurs asymptomatiques à la fin de la saison de transmission (décembre) dans une zone rurale du Mali.

Malipaludismeobserved décembreHAL · Unilimdocument of 214 observations

37 %Malaria has a morbidity rate of 37% in Mali.

MalipaludismeHAL · Unilimdocument of 95 observations

100 %After correction for cases of re-infection, the cure rate for artesunate-sulfamethoxypyrazine-pyrimethamine was 100% and for artemether-lumefantrine was 99.0%.

Malipaludismeobserved 2003 and 2004published 2006The American journal of tropical medicine and hygieneeurope_pmcdocument of 4 observationsDOI 10.4269/ajtmh.2006.75.630

1 %La prévalence du paludisme au Mali varie de 1 % dans le district sanitaire de Bamako à 30 % dans la région de Sikasso.

MalipaludismeHAL · Unilimdocument of 214 observations

3,204,275 casEn 2020, les formations sanitaires du Mali ont enregistré 3 204 275 cas confirmés de paludisme avec 1480 décès.

Malipaludismeobserved 2020HAL · Unilimdocument of 214 observations